Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue

NCT05778110 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-05-03

No results posted yet for this study

Summary

The goal of this experimental observation study is to figure out differently expressed biomarkers in lesion tissues in traumatic brain injury or hypertension intracranial hemorrhage patients. The main questions it aims to answer is:

* Which RNA, protein and metabolites are differently expressed in lesion tissues?
* What molecular mechanism is participated in TBI or ICH? Participants will be treated by emergency operation, and their lesion tissues will be collected during the operation.

Conditions

  • Brain Injury Traumatic Severe
  • Intracranial Hemorrhage, Hypertensive

Interventions

OTHER

Type of disease

Different types of pathogen: brain injury by trauma or intracranial hemorrhage due to hypertension.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-03-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05778110 on ClinicalTrials.gov